Biocon Limited (BOM:532523)

Biocon Statistics

Total Valuation

Biocon has a market cap or net worth of INR 693.71 billion. The enterprise value is 835.12 billion.

Market Cap	693.71B
Enterprise Value	835.12B

Important Dates

The last earnings date was Thursday, May 7, 2026.

Earnings Date	May 7, 2026
Ex-Dividend Date	Jul 3, 2026

Share Statistics

Current Share Class	1.62B
Shares Outstanding	n/a
Shares Change (YoY)	+14.12%
Shares Change (QoQ)	+18.58%
Owned by Insiders (%)	46.00%
Owned by Institutions (%)	23.57%
Float	708.71M

Valuation Ratios

The trailing PE ratio is 179.91 and the forward PE ratio is 52.44.

PE Ratio	179.91
Forward PE	52.44
PS Ratio	4.10
PB Ratio	1.89
P/TBV Ratio	13.28
P/FCF Ratio	353.76
P/OCF Ratio	34.79
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.17, with an EV/FCF ratio of 425.86.

EV / Earnings	216.58
EV / Sales	4.93
EV / EBITDA	24.17
EV / EBIT	55.73
EV / FCF	425.86

Financial Position

The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.42.

Current Ratio	1.22
Quick Ratio	0.70
Debt / Equity	0.42
Debt / EBITDA	4.47
Debt / FCF	78.71
Interest Coverage	1.51

Financial Efficiency

Return on equity (ROE) is 1.15% and return on invested capital (ROIC) is 2.69%.

Return on Equity (ROE)	1.15%
Return on Assets (ROA)	1.53%
Return on Invested Capital (ROIC)	2.69%
Return on Capital Employed (ROCE)	3.02%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	10.31M
Profits Per Employee	234,836
Employee Count	16,420
Asset Turnover	0.28
Inventory Turnover	1.03

Taxes

In the past 12 months, Biocon has paid 791.00 million in taxes.

Income Tax	791.00M
Effective Tax Rate	17.66%

Stock Price Statistics

The stock price has increased by +28.14% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+28.14%
50-Day Moving Average	380.32
200-Day Moving Average	376.29
Relative Strength Index (RSI)	68.76
Average Volume (20 Days)	432,436

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biocon had revenue of INR 169.27 billion and earned 3.86 billion in profits. Earnings per share was 2.82.

Revenue	169.27B
Gross Profit	112.36B
Operating Income	14.99B
Pretax Income	4.48B
Net Income	3.86B
EBITDA	34.55B
EBIT	14.99B
Earnings Per Share (EPS)	2.82

Balance Sheet

The company has 38.83 billion in cash and 154.34 billion in debt, with a net cash position of -115.51 billion.

Cash & Cash Equivalents	38.83B
Total Debt	154.34B
Net Cash	-115.51B
Net Cash Per Share	n/a
Equity (Book Value)	366.22B
Book Value Per Share	213.54
Working Capital	31.11B

Cash Flow

In the last 12 months, operating cash flow was 19.94 billion and capital expenditures -17.98 billion, giving a free cash flow of 1.96 billion.

Operating Cash Flow	19.94B
Capital Expenditures	-17.98B
Depreciation & Amortization	19.57B
Net Borrowing	-46.69B
Free Cash Flow	1.96B
FCF Per Share	n/a

Margins

Gross margin is 66.38%, with operating and profit margins of 8.85% and 2.28%.

Gross Margin	66.38%
Operating Margin	8.85%
Pretax Margin	2.65%
Profit Margin	2.28%
EBITDA Margin	20.41%
EBIT Margin	8.85%
FCF Margin	1.16%

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.11%.

Dividend Per Share	0.50
Dividend Yield	0.11%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	23.55%
Buyback Yield	-14.12%
Shareholder Yield	-14.00%
Earnings Yield	0.56%
FCF Yield	0.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 12, 2019. It was a forward split with a ratio of 2.

Last Split Date	Jun 12, 2019
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	8